Budget 2018: Spinal muscular atrophy drug Spinraza to be added to Pharmaceutical Benefits Scheme

Budget 2018: Spinal muscular atrophy drug Spinraza to be added to Pharmaceutical Benefits Scheme  ABC Online From $375000 to just $39.50: Budget lifeline for children suffering spinal muscular atrophy  The Sydney Morning Herald Spinal muscular atrophy drug price slashed  SBSFull coverage

Read More ...
Budget 2018: Spinal muscular atrophy drug Spinraza to be added to Pharmaceutical Benefits Scheme published May 06, 2018 at 06:18AM. Original Source Link : http://www.abc.net.au/news/2018-05-06/spinal-muscular-atrophy-spinraza-pharmaceutical-benefits-scheme/9731138

loading...